Chad Miller

Before cofounding Nosis, Chad worked at the frontier of protein design at Institute for Protein Design (IPD) at the University of Washington under David Baker. Chad led multiple projects at the interface of protein design and immunology, using de novo protein scaffolds to enable a new class of vaccines. This work was funded by the Bill and Melinda Gates Foundation and Amgen.

Prior to joining the IPD, Chad completed a doctorate in Pharmacology at Yale University focusing on cell signaling specificity and rational engineering of kinases. Chad was a recipient of the HHMI translational fellowship and was also selected for the inaugural class of Yale-Canaan Venture Fellows. He has published over 20 papers contributing to mathematical and computational biochemistry, cell signaling, and immunological ligand design. His h-index is 16, and his Erdős number is 2.

At Nosis, Chad oversees all wet lab capabilities, including multiple high-throughput biochemical discovery and validation assays. Chad has expanded the laboratory team by hiring exceptional researchers from academia and industry across multiple disciplines. He is responsible for enabling and coordinating the chemistry, biochemistry, cell biology, and translational functions at Nosis.

Prior to his doctoral studies, Chad earned an M.S. in Chemistry and a B.A. with Honors from Youngstown State University, where he served as President of the Student Government Association.